Dorene M. Rentz, PsyD, is Professor of Neurology at Harvard Medical School and a practicing clinical neuropsychologist for over 35 years. She has dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital.  She serves as the Co-Director of the Center for Alzheimer Research and Treatment. She is also the Co-Clinical Core Leader of the Harvard Aging Brain Study and Co-Leader of the Clinical Outcome Instrument Unit of the Alzheimer Clinical Trial Consortium.

Dr. Rent’s clinical and research interests have focused on early detection of cognitive changes related to preclinical Alzheimer’s disease as well as the impact of cognitive reserve on early detection. She is a recognized leader in the development of novel cognitive outcome measures for secondary prevention trials and the feasibility of mobile technology for assessing cognition in the clinic and home environment. Her latest interest is in understanding the clinically meaningfulness of a treatment for Alzheimer’s disease.

https://www.ncbi.nlm.nih.gov/myncbi/dorene.rentz.1/bibliography/public/